KISSIMMEE, Fla., Oct. 23, 2016 -- More than 20.7 million Americans suffer from chronic dry eye, making it one of the most common causes for visits to the eye doctor. A properly functioning eye creates enough tears to lubricate and protect the eye. When afflicted with dry eye, the patient's eye either makes insufficient tears or tears that are of poor quality. The most common form of dry eye, called keratoconjunctivitis sicca (KCS), occurs when the water layer of the eye is inadequate. When the eye fails to lubricate itself sufficiently with natural tears, the eye can become dry, irritated, red, painful and even scarred from abrasion.
Dr. Saira A. Choudhri, of Eye Care Specialists of Florida, is using PROKERA®, a cutting-edge product for the treatment of dry eye syndrome. PROKERA® is the only U.S. Food and Drug Administration (FDA) approved therapeutic device found to decrease inflammation, while assisting the eye in regenerative healing. "While July was National Dry Eye Awareness Month, this is a condition that is important year round," stated Dr. Choudhri. "This is one of the most frequent conditions I see in practice as a Kissimmee ophthalmologist, and I have been very happy with the results we have seen from using PROKERA® in the treatment of dry eye."
Chronic dry eye can cause symptoms ranging from mild irritation to severe pain. Sufferers of dry eye often feel like something sandy or gritty is stuck in the eye. This sensation comes from the abrasion caused by a lack of sufficient tears. PROKERA® is a biologic corneal bandage that protects the eye and promotes healing. Comprised of FDA-regulated amniotic tissue, PROKERA® can be inserted and removed during the course of normal office visits.
According to Dr. Choudhri, "We have found PROKERA® to be effective due to its protective qualities. It's similar in shape and form to a contact lens. We can easily insert it during an office visit. While the patient wears PROKERA®, the tissue in the bandage works to heal the eye's membranes by protecting it from further irritation and scarring and promotes healing. Dry eye is a common patient complaint, particularly among my older patients and women who have reached menopause. The earlier they make me aware of their discomfort, the earlier we can begin treatment and alleviate their pain."
Eye Care Specialists of Florida is a single-doctor office specializing in the treatment of chronic eye conditions such as dry eye, cataracts, glaucoma and macular degeneration. They are located at 1124 Cypress Glen Circle, Kissimmee, Florida. The office is open Monday through Friday from 8:00 AM to 4:30 PM. To make an appointment or learn more about how PROKERA® can treat dry eye, contact Eye Specialists of Florida at (407) 483-0328. For additional information on their ophthalmology services, visit their website at http://eyecarespecialistsofflorida.com/.
Eye Care Specialists of Florida, (407) 483-0328


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Shares Jump on HBM4 Mass Production Report
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



